$BCRX Recent News Hazmat-suit maker’s shares
Post# of 74550
Posted On: 12/07/2014 9:54:39 PM
$BCRX Recent News
Hazmat-suit maker’s shares jump on Ebola orders 11:49 a.m. Oct. 30, 2014 - Russ Britt
Ebola stocks mostly higher after virus confirmed in New York 1:59 p.m. Oct. 24, 2014 - Joseph Adinolfi
Fighting Ebola though investing: one firm’s approach 5:43 p.m. Oct. 21, 2014 - Wallace Witkowski
Is there an Ebola bubble in these stocks? 2:22 p.m. Oct. 16, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 11:09 a.m. Oct. 13, 2014 - The Trading Deck
U.S. to start screening for Ebola at five airports 5:25 p.m. Oct. 8, 2014 - Russ Britt
Ebola vaccine use likely to be confined, experts say 6:28 a.m. Oct. 8, 2014 - Russ Britt
Number of companies fighting Ebola grows, one wins fed OK 3:09 p.m. Oct. 6, 2014 - Russ Britt
Meet the drug companies fighting Ebola 3:14 p.m. Oct. 3, 2014 - Russ Britt
Getting Ebola treatments to market may take time 2:05 p.m. Oct. 1, 2014 - Russ Britt
Profiting from the fear as the market’s best quarter of the year begins 7:59 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira surges after Ebola report; ADP sinks 7:13 a.m. Oct. 1, 2014 - Ben Eisen
Stock markets start new quarter in good shape. 3:45 a.m. Oct. 1, 2014 - MarketWatch
Newscast: Wall Street notches winning quarter 5:31 p.m. Sept. 30, 2014 - MarketWatch
Use caution when investing in Ebola-related stocks 11:26 a.m. Aug. 28, 2014 - The Trading Deck
In focus: Bulls overconfident? 7:36 p.m. Aug. 13, 2014 - Lawrence G. McMillan
Ebola drug maker's shares soar as FDA opens door to treatment use 11:20 a.m. Aug. 8, 2014 - Russ Britt
6 stocks to watch 2:13 p.m. June 4, 2014 - The Trading Deck
S&P 500 reaches uncharted territory (that’s bullish) 12:00 p.m. March 5, 2014 - Michael Ashbaugh
U.S. stocks rise on ‘buy-the-dip’ mentality 3:31 p.m. April 8, 2013 - Kate Gibson
Biotech industry group supports adding Ebola to Voucher Program Act 1:57 p.m. Dec. 5, 2014 - Seeking Alpha
Brinson Patrick's Christopher S. James: All Catalysts Are Not Created Equal 8:55 a.m. Dec. 5, 2014 - Seeking Alpha
Hydration could save many Ebola victims 7:19 a.m. Dec. 5, 2014 - Seeking Alpha
UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals Following EU Physicians Survey 9:27 a.m. Dec. 4, 2014 - benzinga.com
5 Critical Biotech Drug Dates and Events for December 1:23 p.m. Dec. 1, 2014 - 247WallSt.com
2nd Half Of 2014 Biotechnology Catalysts: Part 5 9:59 a.m. Dec. 1, 2014 - Seeking Alpha
December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey 6:00 a.m. Nov. 26, 2014 - TheStreet.com
5 Stocks to Watch Closely for the Rest of 2014 2:38 a.m. Nov. 26, 2014 - InvestorPlace.com
Aethlon Medical up on successful Ebola treatment 12:06 p.m. Nov. 17, 2014 - Seeking Alpha
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak 4:24 p.m. Nov. 13, 2014 - Seeking Alpha
These Ebola Stocks Have It All Riding on Africa Drug Trials 4:17 a.m. Nov. 13, 2014 - InvestorPlace.com
Ebola Stock Short Interest Surprise 1:44 p.m. Nov. 12, 2014 - 247WallSt.com
Why We Are Short Tekmira 10:48 a.m. Nov. 10, 2014 - Seeking Alpha
4 Stocks to Look at via Ebola Crisis - Analyst Blog 10:43 a.m. Nov. 10, 2014 - Zacks.com
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape 8:44 a.m. Nov. 10, 2014 - Zacks.com
BioCryst Pharmaceuticals' (BCRX) CEO Jon Stonehouse on Q3 2014 Results - Earnings Call Transcript 11:45 p.m. Nov. 8, 2014 - Seeking Alpha
10-Q: BIOCRYST PHARMACEUTICALS INC 4:18 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
BioCryst Pharmaceuticals (BCRX) Q3 2014 Results - Earnings Call Webcast 10:55 a.m. Nov. 6, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Nov. 5, 2014 - Seeking Alpha
CDC issues new guidelines over Ebola 4:10 a.m. Oct. 28, 2014 - Seeking Alpha
Bellicum Announces New Director, Executive Management Appointments 7:58 a.m. Dec. 5, 2014 - BusinessWire - BZX
BioCryst to Present at Two Upcoming Investor Conferences 7:10 a.m. Nov. 20, 2014 - GlobeNewswire
BioCryst Reports Third Quarter 2014 Financial Results 6:48 a.m. Nov. 6, 2014 - GlobeNewswire
BioCryst to Announce Third Quarter 2014 Financial Results November 6 5:56 a.m. Oct. 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014 5:59 a.m. Oct. 8, 2014 - GlobeNewswire
BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress 6:07 a.m. Oct. 7, 2014 - GlobeNewswire
Critical Alerts For Alibaba, BioCryst Pharmaceuticals, Trina Solar Limited, Vipshop Holdings and Visa Released By InvestorsObserver 8:31 a.m. Oct. 2, 2014 - PR Newswire - PRF
BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases 11:07 a.m. Sept. 18, 2014 - GlobeNewswire
BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting 10:00 a.m. Sept. 6, 2014 - GlobeNewswire
BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies 1:31 a.m. Sept. 4, 2014 - GlobeNewswire
BioCryst to Present at Rodman & Renshaw Conference 5:35 a.m. Sept. 3, 2014 - GlobeNewswire
BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting 5:52 a.m. Sept. 2, 2014 - GlobeNewswire
BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease 6:07 a.m. Aug. 29, 2014 - GlobeNewswire
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases 6:04 a.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 2:04 p.m. Aug. 12, 2014 - ACCESSWIRE
BioCryst Reports Second Quarter 2014 Financial Results 5:56 a.m. Aug. 5, 2014 - GlobeNewswire
BioCryst to Announce Second Quarter 2014 Financial Results August 5 6:06 a.m. July 22, 2014 - GlobeNewswire
Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum Pharma, Exact Sciences, and Vical Inc. 8:10 a.m. July 21, 2014 - PR Newswire - PRF
Hazmat-suit maker’s shares jump on Ebola orders 11:49 a.m. Oct. 30, 2014 - Russ Britt
Ebola stocks mostly higher after virus confirmed in New York 1:59 p.m. Oct. 24, 2014 - Joseph Adinolfi
Fighting Ebola though investing: one firm’s approach 5:43 p.m. Oct. 21, 2014 - Wallace Witkowski
Is there an Ebola bubble in these stocks? 2:22 p.m. Oct. 16, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 11:09 a.m. Oct. 13, 2014 - The Trading Deck
U.S. to start screening for Ebola at five airports 5:25 p.m. Oct. 8, 2014 - Russ Britt
Ebola vaccine use likely to be confined, experts say 6:28 a.m. Oct. 8, 2014 - Russ Britt
Number of companies fighting Ebola grows, one wins fed OK 3:09 p.m. Oct. 6, 2014 - Russ Britt
Meet the drug companies fighting Ebola 3:14 p.m. Oct. 3, 2014 - Russ Britt
Getting Ebola treatments to market may take time 2:05 p.m. Oct. 1, 2014 - Russ Britt
Profiting from the fear as the market’s best quarter of the year begins 7:59 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira surges after Ebola report; ADP sinks 7:13 a.m. Oct. 1, 2014 - Ben Eisen
Stock markets start new quarter in good shape. 3:45 a.m. Oct. 1, 2014 - MarketWatch
Newscast: Wall Street notches winning quarter 5:31 p.m. Sept. 30, 2014 - MarketWatch
Use caution when investing in Ebola-related stocks 11:26 a.m. Aug. 28, 2014 - The Trading Deck
In focus: Bulls overconfident? 7:36 p.m. Aug. 13, 2014 - Lawrence G. McMillan
Ebola drug maker's shares soar as FDA opens door to treatment use 11:20 a.m. Aug. 8, 2014 - Russ Britt
6 stocks to watch 2:13 p.m. June 4, 2014 - The Trading Deck
S&P 500 reaches uncharted territory (that’s bullish) 12:00 p.m. March 5, 2014 - Michael Ashbaugh
U.S. stocks rise on ‘buy-the-dip’ mentality 3:31 p.m. April 8, 2013 - Kate Gibson
Biotech industry group supports adding Ebola to Voucher Program Act 1:57 p.m. Dec. 5, 2014 - Seeking Alpha
Brinson Patrick's Christopher S. James: All Catalysts Are Not Created Equal 8:55 a.m. Dec. 5, 2014 - Seeking Alpha
Hydration could save many Ebola victims 7:19 a.m. Dec. 5, 2014 - Seeking Alpha
UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals Following EU Physicians Survey 9:27 a.m. Dec. 4, 2014 - benzinga.com
5 Critical Biotech Drug Dates and Events for December 1:23 p.m. Dec. 1, 2014 - 247WallSt.com
2nd Half Of 2014 Biotechnology Catalysts: Part 5 9:59 a.m. Dec. 1, 2014 - Seeking Alpha
December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey 6:00 a.m. Nov. 26, 2014 - TheStreet.com
5 Stocks to Watch Closely for the Rest of 2014 2:38 a.m. Nov. 26, 2014 - InvestorPlace.com
Aethlon Medical up on successful Ebola treatment 12:06 p.m. Nov. 17, 2014 - Seeking Alpha
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak 4:24 p.m. Nov. 13, 2014 - Seeking Alpha
These Ebola Stocks Have It All Riding on Africa Drug Trials 4:17 a.m. Nov. 13, 2014 - InvestorPlace.com
Ebola Stock Short Interest Surprise 1:44 p.m. Nov. 12, 2014 - 247WallSt.com
Why We Are Short Tekmira 10:48 a.m. Nov. 10, 2014 - Seeking Alpha
4 Stocks to Look at via Ebola Crisis - Analyst Blog 10:43 a.m. Nov. 10, 2014 - Zacks.com
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape 8:44 a.m. Nov. 10, 2014 - Zacks.com
BioCryst Pharmaceuticals' (BCRX) CEO Jon Stonehouse on Q3 2014 Results - Earnings Call Transcript 11:45 p.m. Nov. 8, 2014 - Seeking Alpha
10-Q: BIOCRYST PHARMACEUTICALS INC 4:18 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
BioCryst Pharmaceuticals (BCRX) Q3 2014 Results - Earnings Call Webcast 10:55 a.m. Nov. 6, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Nov. 5, 2014 - Seeking Alpha
CDC issues new guidelines over Ebola 4:10 a.m. Oct. 28, 2014 - Seeking Alpha
Bellicum Announces New Director, Executive Management Appointments 7:58 a.m. Dec. 5, 2014 - BusinessWire - BZX
BioCryst to Present at Two Upcoming Investor Conferences 7:10 a.m. Nov. 20, 2014 - GlobeNewswire
BioCryst Reports Third Quarter 2014 Financial Results 6:48 a.m. Nov. 6, 2014 - GlobeNewswire
BioCryst to Announce Third Quarter 2014 Financial Results November 6 5:56 a.m. Oct. 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014 5:59 a.m. Oct. 8, 2014 - GlobeNewswire
BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress 6:07 a.m. Oct. 7, 2014 - GlobeNewswire
Critical Alerts For Alibaba, BioCryst Pharmaceuticals, Trina Solar Limited, Vipshop Holdings and Visa Released By InvestorsObserver 8:31 a.m. Oct. 2, 2014 - PR Newswire - PRF
BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases 11:07 a.m. Sept. 18, 2014 - GlobeNewswire
BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting 10:00 a.m. Sept. 6, 2014 - GlobeNewswire
BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies 1:31 a.m. Sept. 4, 2014 - GlobeNewswire
BioCryst to Present at Rodman & Renshaw Conference 5:35 a.m. Sept. 3, 2014 - GlobeNewswire
BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting 5:52 a.m. Sept. 2, 2014 - GlobeNewswire
BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease 6:07 a.m. Aug. 29, 2014 - GlobeNewswire
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases 6:04 a.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 2:04 p.m. Aug. 12, 2014 - ACCESSWIRE
BioCryst Reports Second Quarter 2014 Financial Results 5:56 a.m. Aug. 5, 2014 - GlobeNewswire
BioCryst to Announce Second Quarter 2014 Financial Results August 5 6:06 a.m. July 22, 2014 - GlobeNewswire
Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum Pharma, Exact Sciences, and Vical Inc. 8:10 a.m. July 21, 2014 - PR Newswire - PRF
(0)
(0)